In December 2023, we completed the asset transfer of CUTX-101 to Sentynl Therapeutics (“Sentynl”), a wholly owned subsidiary of Zydus Lifesciences Ltd. Sentynl completed the rolling submission of the ...

The recent approval enables Zydus Lifesciences to produce and sell Apalutamide Tablets, 60 mg (a generic equivalent of Erleada) in the United States. Apalutamide is an androgen receptor inhibitor ...

Ahmedabad: Pharma major, Zydus Lifesciences Limited, has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Apalutamide Tablets, 60 mg (Erleada Tablets, ...

Zydus Lifesciences share price: Pharmaceutical company Zydus Lifesciences shares were buzzing in trade on Wednesday, March 19, 2025, as the scrip rose as much as 3.04 per cent to hit an intraday high ...

Stock Market Focus IndusInd Bank, Zydus, Dr. Reddy’s, More Zee Business Video Team | Updated: March 19, 2025 10:24 AM IST Which stocks will be in focus today including Indusind Bank, Zydus ...

Zydus Lifesciences received final USFDA approval to manufacture Apalutamide tablets for prostate cancer, following last week's approval for Eluxadoline tablets for IBS treatment. The stock shows a ...

The Board has extended Rajivnayan Rahulkumar Bajaj's tenure as Managing Director and Chief Executive Officer for another five years, starting April 1. Additionally, Abhinav Bindra has been ...

Zydus Lifesciences Limited announced on Tuesday that it has secured the final approval from the United States Food and Drug Administration (USFDA) for manufacturing and marketing apalutamide ...

The Board has re-appointed Rajivnayan Rahulkumar Bajaj as the Managing Director & Chief Executive Officer of the company for five consecutive years, effective April 1. Additionally, Abhinav Bindra ...

Zydus Lifesciences Ltd. has received final nod from the United States Food and Drug Administration to manufacture 60 mg Apalutamide tablets, according to an exchange filing on Tuesday. Apalutamide is ...

Drug maker Zydus Lifesciences Ltd on Tuesday (March 18) said it has received the final approval from the United States Food and Drug Administration (FDA) to manufacture and market apalutamide tablets, ...

Zydus Lifesciences: The drug maker has received final approval from the US FDA to manufacture Apalutamide tablets in a 60 mg strength. (DISCLAIMER: The views and opinions expressed by investment ...